Vielight Inc.
Vielight Inc. designs, develops, and manufactures home-use photobiomodulation (PBM) devices for brain health, systemic wellness, and clinical research. The company specializes in non-invasive transcranial and intranasal light therapy systems, including solutions for neural and systemic applications. Their technology is ISO 13485:2016 and MDSAP certified, utilized in over 35 clinical trials, and supported by a significant patent portfolio. Functional outcomes studied include cognitive enhancement, neurological conditions, immune support, brain-body connectivity, and mental well-being. Vielight offers products for professional, research, and consumer use worldwide, and collaborates with leading research institutions.
Industries
N/A
Products
A modular, non-invasive device featuring both transcranial and intranasal LED-based light delivery to target brain networks for cognitive, neurological, and wellness support. Offers selectable Alpha (10 Hz) and Gamma (40 Hz) stimulation modes.
A research-grade guided photobiomodulation system with 12 modular LED modules and 9 preset protocols. Offers full app control for targeting various brain networks, enabling advanced customization, and supporting clinical and research applications.
Non-invasive device for bilateral vagus nerve stimulation using LED-based light therapy, designed to enhance brain-body connectivity, mental clarity, systemic wellness, and stress reduction.
Modular light therapy systems utilizing multiple wavelengths to support immunity, oxygenation, and systemic wellness via nasal, thymus, or other superficial stimulation.
Artificial intelligence-driven software for analyzing and guiding personalized brain photobiomodulation protocols based on EEG data and user feedback.
A non-invasive modular helmet device delivering 810nm near-infrared light at 10 Hz (Alpha mode) via adjustable LED arrays and an intranasal applicator. Targets the Default Mode Network for relaxation, sleep improvement, stress reduction, and support of cognitive processes.
A modular, non-invasive device featuring both transcranial and intranasal LED-based light delivery to target brain networks for cognitive, neurological, and wellness support. Offers selectable Alpha (10 Hz) and Gamma (40 Hz) stimulation modes.
A research-grade guided photobiomodulation system with 12 modular LED modules and 9 preset protocols. Offers full app control for targeting various brain networks, enabling advanced customization, and supporting clinical and research applications.
Non-invasive device for bilateral vagus nerve stimulation using LED-based light therapy, designed to enhance brain-body connectivity, mental clarity, systemic wellness, and stress reduction.
Modular light therapy systems utilizing multiple wavelengths to support immunity, oxygenation, and systemic wellness via nasal, thymus, or other superficial stimulation.
Artificial intelligence-driven software for analyzing and guiding personalized brain photobiomodulation protocols based on EEG data and user feedback.
A non-invasive modular helmet device delivering 810nm near-infrared light at 10 Hz (Alpha mode) via adjustable LED arrays and an intranasal applicator. Targets the Default Mode Network for relaxation, sleep improvement, stress reduction, and support of cognitive processes.
Services
Expert consultation to assist with device selection, scientific clarification, and clinical implementation of non-invasive light therapy technologies for brain and systemic applications.
Expert consultation to assist with device selection, scientific clarification, and clinical implementation of non-invasive light therapy technologies for brain and systemic applications.
Expertise Areas
- Brain photobiomodulation research
- Non-invasive neuromodulation
- Clinical trial management for neurological and psychiatric applications
- AI-driven brain stimulation protocols
Key Technologies
- Photobiomodulation
- Near-infrared and red light therapy
- Transcranial brain stimulation using LEDs
- Intranasal light delivery systems
Key People
Chief Financial Officer
Chief Financial Officer
News & Updates
Holds one of the largest global patent portfolios for non-invasive brain photobiomodulation, including AI-driven and vagus nerve applications.
Achieved international standards for quality management in medical device manufacturing.
Obtained medical device registration in North America for select PBM products.
Summary of published independent research from UCSF showing improved cerebral blood flow and functional connectivity in Alzheimer’s patients using near-infrared PBM, validated via fMRI.
Overview of studies detailing increased cerebellar network efficiency in traumatic brain injury participants following intranasal-transcranial PBM interventions.
Synopsis of clinical trial outcomes in Parkinson’s disease using transcranial-intranasal PBM, including improvements in cognitive and motor functions.
Holds one of the largest global patent portfolios for non-invasive brain photobiomodulation, including AI-driven and vagus nerve applications.
Achieved international standards for quality management in medical device manufacturing.
Obtained medical device registration in North America for select PBM products.
Summary of published independent research from UCSF showing improved cerebral blood flow and functional connectivity in Alzheimer’s patients using near-infrared PBM, validated via fMRI.
Overview of studies detailing increased cerebellar network efficiency in traumatic brain injury participants following intranasal-transcranial PBM interventions.
Synopsis of clinical trial outcomes in Parkinson’s disease using transcranial-intranasal PBM, including improvements in cognitive and motor functions.